Medios AI
Remidio
CE markeddiabetic retinopathy
Offline deep-learning algorithm that runs on a smartphone-based fundus camera to flag referable diabetic retinopathy within seconds.
- Company
- Remidio
- Category
- Screening
- Reads
- Fundus images from the Remidio NM-FOP smartphone-based camera
- Built for
- Community and primary-care screening outside the US
- Billing
- Check vendor
- Regulatory
- CE mark under EU MDR Class II announced Feb 23, 2023; also approved by Singapore HSA. Press coverage states it is not FDA-approved and not sold in the US. · source
- Last verified
- 2026-10-07
DotAEye is independent of Remidio. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.